Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

IO

This page shows the latest IO news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca to present new oncology data at AACR

AstraZeneca to present new oncology data at AACR

It will include data from 60 presentations – including five oral and three mini-oral presentations – and will feature AZ’s next phase of potential cancer treatments covering its immuno-oncology (IO), ... Bispecific antibodies are a promising IO

Latest news

More from news
Approximately 7 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Putting the ovation into innovation: trends from ESMO Putting the ovation into innovation: trends from ESMO

    Immuno-oncology remains key. The promise of immuno-oncology (IO) shows no sign of abating, with current efforts focused on increasing responder rates. ... Neoadjuvant and first- line IO with checkpoint inhibitors continues to bring benefits across

  • Immuno-oncology in 2019: the rapid evolution continues Immuno-oncology in 2019: the rapid evolution continues

    However, the company continues to study Opdivo in trials twinned with a very wide range of novel agents, with the hope of finding a combination which can take immuno-oncology (IO)

  • Immunotherapy combination trials Q&A Immunotherapy combination trials Q&A

    What factors should sponsors weigh up when planning a new IO trial in 2019 and beyond? ... Through these concerted efforts, meaningful progress in IO will have its best chance.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Merck/MSD looks to have gained a dominant position in checkpoint inhibitor immuno-oncology (IO) with Keytruda – but there remains room for growth in the market via new IO agents. ... This is particularly the case for the considerable percentage of

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    Of course, AstraZeneca isn’t immune to the setbacks of old – its IO drug Imfinzi is witness to that. ... This gives it a unique niche in an IO lung cancer market dominated by Merck &Co’s Keytruda, and prevented it from being an also-ran.

More from intelligence
Approximately 2 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Envision Pharma Group and Alucio™ partner to power next-generation scientific exchange for the life science industry Envision Pharma Group and Alucio™ partner to power next-generation scientific exchange for the life science industry

    Collaboration capitalizes on Alucio’s flagship Beacon platform and Envision’s global leadership in medical strategy and healthcare communications. Envision Pharma Group (Envision) and Alucio today announced a global partnership to power impactful

  • Using Cybersecurity to Maintain Patient Data Integrity

    Christina Stokes, Founder of CyberRhythms Consulting and Writer at CyberSolace.io, explores cybersecurity in healthcare, the importance of keeping patient data safe (and the consequences of a breach), and current/future

  • Moving Minds

    Moving Minds is an award-winning on demand marketing+technology agency enabling forward-thinking companies to get to market faster and smarter with ‘Growth as a Managed Service,’ a fractional, more agile #martech model designed for CXOs.

  • Medical Device Clinical Trials 2020 Medical Device Clinical Trials 2020

    In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people, while catching up on the latest in the industry. Here, we’ve

  • New Leaf Technology Solutions Ltd

    Before founding New Leaf Technology Solutions, Simon Chambers and his co-founder worked for a decade exclusively with the Pharmaceutical Industry, leading and delivering cutting edge business applications targeting the SFE market in areas such as

More from PMHub
Approximately 1 fully matching, plus 14 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...

Quick links